Abstract
Background
We evaluated cisplatin and 5-fluorouracil as preoperative adjuvant chemotherapy for patients with locally advanced squamous esophageal cancer and compared two different infusion regimens. The outcomes were also compared with those of our historical control patients treated by surgery alone.
Methods
From 1991 to 1997, 83 consecutive esophageal cancer patients underwent surgical exploration after completion of two cycles of cisplatin and 5-fluorouracil chemotherapy regimens, either in pulse or in continuous infusion cycles. Outcomes were compared with those of 76 historical control patients. Both groups were comparable in demographic characteristics and tumor stages. The resection rates, operative morbidity, mortality, and survival rates were compared.
Results
Partial response was achieved in 50% of patients who received chemotherapy. There was no chemotherapy-related mortality. The resection, morbidity, and mortality rates and median survival between the surgery-alone group and the chemotherapy group were 71.1% vs. 82%, 51% vs. 55%, and 4% vs. 10.8%, 12.0 vs. 13.5 months, respectively (P>.05). There was also no statistically significant difference between the two regimens.
Conclusions
Preoperative adjuvant chemotherapy with cisplatin and 5-fluorouracil infusion, in pulse or continuous regimens, followed by surgery for squamous esophageal cancer patients had no added benefit in the overall survival.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Skinner DB. En bloc resection for neoplasms of the esophagus and cardia.J. Thorac Cardiovasc Surg 1983;85:59–71.
Akiyama H, Tsurumaru M, udagawa H, Kajiyama Y. Radical lymph node dissection for cancer of the thoracic esophagus.Ann Surg 1994;220:364–72.
Holscher AH, Bollschweiler E, Schneider PM, Siewert JR. Prognosis of early esophageal cancer. Comparison between adeno- and squamous cell carcinoma.Cancer 1995;76:178–86.
Earlam R, Cunha-Melo JR. Esophageal squamous cell carcinoma: I. A critical review of surgery.Br J Surg 1980;67:381–90.
Muller JM, Erasmi H, Stelzner M, Zieren U, Pichlmaier H. Surgical therapy of esophageal carcinoma.Br J Surg 1990;77:845–57.
Gurther GC, Robertson CS, Chung SC, Li AK. Two-team synchronous oesophagectomy.Br J Surg 1994;81:1620–2.
Carey RW, Hilgenberg AD, Choi NC, et al. A pilot study of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and postoperative radiation therapy and/or chemotherapy in adenocarcinoma of the esophagus.Cancer 1991;68: 489–92.
Kies MS, Rosen ST, Tsang TK, et al. Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer.Cancer 1987;60:2156–60.
De Besi P, Sileni VC, Salvagno L, et al. Phase II study of cisplatin, 5-FU, and allopurinol in advanced esophageal cancer.Cancer Treat Rep 1986;70:909–10.
Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. The Chirurgische Arbeitsgemeinschaft fuer Onkologie der Deutschen Gesellschaft fuer Chirurgie Study Group.Arch Surg 1992;127:1446–50.
Roth JA, Pass HI, Flanagan MM, Graeber GM, Rosenberg JC, Steinberg S. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with cisplatin, vindesine, and bleomycin for carcinoma of the esophagus.J Thorac Cardiovasc Surg 1988;96:242–8.
Kelsen DP, Minsky B, Smith M, et al. Preoperative therapy for esophageal cancer: a randomized comparison of chemotherapy versus radiation therapy.J Clin Oncol 1990;8:1352–61.
Kelsen DP, Ginsberg R, Pajak TF, et al. Chemotherapy followed by surgery compared with surgery alone for localized esophageal cancer.N Engl J Med 1998;339:1979–84.
Griffith JF, Chan ACW, Ahuja AT, et al. Neck ultrasound in staging squamous esophageal carcinoma—a high yield technique.Clin Radiol 2000;55:696–701.
Findlay M, Cunningham D, Norman A, et al. A phase II study in advanced gastro-esophageal cancer using epirubicin and cisplatin in combination with continuous infusion 5-fluorouracil (ECF).Ann Oncol 1994;5:609–16.
Highley MS, Parnis FX, Trotter GA, et al. Combination chemotherapy with epirubicin, cisplatin and 5-fluorouracil for the palliation of advanced gastric and esophageal adenocarcinoma.Br J Surg 1994;81:1763–5.
Liang EY, Chan A, Chung SC, Metreweli C. Short communication: esophageal tumor volume measurement using spiral CT.Br J Radiol 1996;69:344–7.
Griffith JF, Chan ACW, Chow LTC, et al. Assessing chemotherapy response of esophageal carcinoma with spiral CT.Br J Radiol 1999;72:678–84.
Nygaard K, Hagen S, Hansen HS, et al. Pre-operative radiotherapy prolongs survival in operable esophageal carcinoma: a randomized, multicenter study of pre-operative radiotherapy and chemotherapy. The second Scandinavian trial in esophageal cancer.World J Surg 1992;16:1104–9.
MRC Upper GI Tract Cancer Group. Medical Research Council (MRC) randomized phase III trial of surgery with or without pre-operative chemotherapy in resectable cancer of the oesophagus (abstract).Br J Cancer 2000;83(Suppl 1):1.
Matsubara T, Ueda M, Nakajima T. Preoperative assessment of lymph nodes in the prediction of disease spread and outcome in cancer of the thoracic esophagus.Br J Surg 1995;82:356–9.
Roubein LD, Dubrow R, David C, et al. Endoscopic ultrasonography in the quantitative assessment of response to chemotherapy in patients with adenocarcinoma of the esophagus and esophagogastric junction.Endoscopy 1993;25:587–91.
Hordijk ML, Kok TC, Wilson JH, Mulder AH. Assessment of response of esophageal carcinoma to induction chemotherapy.Endocropy 1993;25:592–6.
Fok M, Sham JS, Choy D, Cheng SW, Wong J. Postoperative radiotherapy for carcinoma of the esophagus: a prospective, randomized controlled study.Surgery 1993;113:138–47.
Goldminc M, Maddern G, Le Prise E, Meunier B, Campion JP, Launois B. Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial.Br J Surg 1993;80:367–70.
Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment.Cancer 1981;47:207–14.
Forastiere AA, Heitmiller RF, Lee DJ, et al. Intensive chemoradiation followed by esophagectomy for squamous cell and adenocarcinoma of the esophagus.Cancer J Sci Am 1997;3:144–52.
Le Prise E, Etienne PL, Meunier B, et al. A randomized study of chemotherapy, radiation therapy, and surgery versus surgery for localized squamous cell carcinoma of the esophagus.Cancer 1994; 73:1779–84.
Bosset JF, Gignoux M, Triboulet JP, et al.. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus.N Engl J Med 1997;337:161–7.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chan, A.C.W., Lee, D.W.H., Griffith, J.F. et al. The clinical efficacy of neoadjuvant chemotherapy in squamous esophageal cancer: A prospective nonrandomized study of pulse and continuous-infusion regimens with cisplatin and 5-fluorouracil. Annals of Surgical Oncology 9, 617–624 (2002). https://doi.org/10.1007/BF02574476
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02574476